Avoiding The Common Pitfall in DX ExecutionYokogawa1
Artificial intelligence (AI), machine learning (ML) and digital twin are the decision support tools of the century. They have now become synonymous with digital transformation. On paper and at face value they deliver phenomenal value. But too many people ignore the hard data plumbing work that needs to precede any of these kinds of initiatives. The AI, ML and digital twin engines can be working fine, but still output poor answers, or not perform at the speed which they’re meant to. This is usually because the fundamental readiness step has been underestimated and not undertaken fully. With reference to various industry case studies, this presentation will explore the fundamental readiness steps of any DX initiative needed to be taken as well as several incremental “quick wins” to score on your way to a more advanced data landscape. The presentation will also opine on some consequences when the readiness step is insufficiently addressed.
Avoiding The Common Pitfall in DX ExecutionYokogawa1
Artificial intelligence (AI), machine learning (ML) and digital twin are the decision support tools of the century. They have now become synonymous with digital transformation. On paper and at face value they deliver phenomenal value. But too many people ignore the hard data plumbing work that needs to precede any of these kinds of initiatives. The AI, ML and digital twin engines can be working fine, but still output poor answers, or not perform at the speed which they’re meant to. This is usually because the fundamental readiness step has been underestimated and not undertaken fully. With reference to various industry case studies, this presentation will explore the fundamental readiness steps of any DX initiative needed to be taken as well as several incremental “quick wins” to score on your way to a more advanced data landscape. The presentation will also opine on some consequences when the readiness step is insufficiently addressed.
Detailed case study on enterprise-grade data management application, custom-designed to cater the backend of an analytics-based fluid composition software deployed across renowned oil and gas industry clients.
Increasing Fab yields by use of big data power, based on GT data mining. GT strengths in this relevance are its ability to find root-causes, using unsupervised data, and creating simple controls that can be embedded in existing systems.
Novartis introduced i-nexus to more effectively control and report on capital expenditure and to facilitate enhanced IQP (Innovation Quality Productivity) project management. The i-nexus Capital Expenditure and Operational Excellence StartPoint solutions have projects that have been initiated in divisions including pharma, vaccines and diagnostics, and consumer health.
There are many aspects, components and dependencies to consider when designing and improving a comprehensive technology environment for passing audits or compliance readiness. This framework was created by Mark Mahre back in 2015, revised in 2017 and improved again in January 2019 to help our clients' leadership, stakeholders and technology management teams understand the breadth of the 'current-state' environment and then help articulate the many moving targets and critical controls requirements for 'future-state' planning, budgeting, executing, testing, operations hand-off, monitoring and sustainability.
Detailed case study on enterprise-grade data management application, custom-designed to cater the backend of an analytics-based fluid composition software deployed across renowned oil and gas industry clients.
Increasing Fab yields by use of big data power, based on GT data mining. GT strengths in this relevance are its ability to find root-causes, using unsupervised data, and creating simple controls that can be embedded in existing systems.
Novartis introduced i-nexus to more effectively control and report on capital expenditure and to facilitate enhanced IQP (Innovation Quality Productivity) project management. The i-nexus Capital Expenditure and Operational Excellence StartPoint solutions have projects that have been initiated in divisions including pharma, vaccines and diagnostics, and consumer health.
There are many aspects, components and dependencies to consider when designing and improving a comprehensive technology environment for passing audits or compliance readiness. This framework was created by Mark Mahre back in 2015, revised in 2017 and improved again in January 2019 to help our clients' leadership, stakeholders and technology management teams understand the breadth of the 'current-state' environment and then help articulate the many moving targets and critical controls requirements for 'future-state' planning, budgeting, executing, testing, operations hand-off, monitoring and sustainability.
• Overall IT experience 14+ Yrs on implementation and Production support phases in Agile and Waterfall .Arvind is experienced Agile Scrum Master on implementation and Transformation phases ,IT-Project Manager– on Agile Distributed multi vendor, multi / HierarchicalPO, multiple geography environment ; Project Lead on (Waterfall)24*7 Production Support at PAN India Level for one of major Telecom client.
• As Scrum Master, Arvind delivered projects on various technology like SAP (Transformation from Waterfall to Agile), .NET, HYBRIS, APIGEE and Oracle eBS.
• Arvind is part of Agile Center of Excellence (CoE).
• Delivered trainings on Agile of ~90 hrs to Projects, teams, Clients and Green Filed.
• Experienced as a Sr. Research Fellow on Geographical Information System (GIS) and Remote Sensing with Indian Council of Agriculture Research (ICAR), Govt Of India.
Successful projects are defined with strong project methodology and experience. RKL eSolutions implements and supports Sage using a proven methodology. Here's how we do it.
Migrating to Cloud: Inhouse Hadoop to Databricks (3)Knoldus Inc.
Modernize your Enterprise Data Lake to Serverless Data Lake, where data, workloads, and orchestrations can be automatically migrated to the cloud-native infrastructure.
20150708 Kanban Meetup An Unexpected Journey: Improving a Scrum Implementatio...Craeg Strong
Over the last five years, Scrum has made significant advances and is now the best-known and most popular Agile framework by a wide margin. However, in recent years Kanban has emerged as an alternative to Scrum. Many companies are attracted to Kanban due to the promise of a flatter learning curve, easier adoption, and wider applicability beyond just IT to other parts of the company. But – is Kanban really an alternative to Scrum? And what is Scrumban, anyway? This talk describes our experiences transforming a mission-critical criminal justice program for the Federal Government from waterfall to Scrum, and how the Kanban Method has given us the tools to address some significant challenges to our Scrum implementation. This talk should help you answer some important questions such as:
• Within the Agile framework what exactly is Scrum, Kanban and Scrumban? What are the similarities and differences?
• What criteria should be used to choose an Agile method?
• How do we get started?
• If we run into obstacles, what techniques can we apply to help move forward?
• Why should I consider a physical board if I already have a tool?
• I know about visual boards, so does that mean I already know Kanban?
GSK Project Management for the Academy of LogisticsMargaret D.
This was my proposal made to the new Director and new management in Logistics after a re-org (GSK Manufacturing Division). Note: some words were purposely spelled with the UK conventions given that half of the audience was from the UK, e.g. programme, utilisation, etc.
Since this information is outdated, it is no longer sensitive and can be seen publicly.
GSK Logistics' Academy of Learning - v2.0 recommendation Note: graphically, t...Margaret D.
This is one of my presentations when consulting for ManPower/GSK. I was the Project Manager for the logistics team responsible for creating the Academy of Learning (worldwide intranet port) for training and support of GSK SOPs, GxP compliance, and more.
There is nothing proprietary about this since the information is dated.
My Presentation on Technology in Corporate Governance & Ethics ClassMargaret D.
I created this slide deck and taught it to the MBA class. Chapter 12 on Technology in Corporate Governance & Ethics was outdated. So, I scrapped the entire chapter, did all of the research and re-wrote it with updated facts and appeal. The teacher liked it so much that he sent a copy of it to the book's author. Note: almost every slide has "action", but SlideShare cannot show it unless you download the entire deck and run it locally.
Tools Risk Analysis - Initial Merger AssessmentsMargaret D.
Application Framework team initial assessments. These are screen captures from the Pharma IT intranet website converted to Word (with edits). I wrote most of the content, the color-coding was my idea. I mostly collaborated with personnel in Philadelphia (SB) to decide the risk levels of each software component. I was based in RTP, NC, so most of the collaboration was by phone with some video-teleconferencing of meetings.
This information is now obsolete, so it is no longer sensitive to the company.
This is a sample of my monthly status report -- one of many in years of Pharma IT management and consulting. This information is no longer sensitive, so no modifications have been made.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Telehealth Psychology Building Trust with Clients.pptx
Weekly status update margaret - 21 jan - redacted
1. Page 1 • Weekly IT Status Update R&D
R&D IT Integration Activities
Outstanding Decisions, Risks & Issues Mitigation or Resolution Approach Status
Behind schedule on receiving a copy of the SARA Source code, a critical tool to any
system reverse engineering process. Risk Exit TSA deadline and/or lack of meeting
business requirements for a GxP system if we have to reinvent the wheel.
Be given online access to the source code as is seemingly available to AMS.
Leads Functional: Margaret
Dischler
Oversight: Redacted
# Priority Project / Initiative Scope Time Budget Staffing
1 SARAcle
2 Legacy SARA Retirement
3 LabWatch – R&D
4 CMS – Pilot Lab
AS OF: 01/21/2015Overall Status: Green
Legend Complete On Track Risk of Delay Delayed
Began SARAcle Migration Process (Service Request #72); this is well
underway with all necessary players engaged and working together
Worked with BBTS on staffing decision for the development effort on
SARAcle; BBTS is decision leaning towards outsourcing
Continued reverse engineering activities for SARAcle
Key Accomplishments (Past Week)
Finalize team decision with BBTS re: in-house or outsourcing SARAcle development
Start and possibly complete actual physical migration of SARAcle to Bayer environment (PB Data Center)
Further data mapping to SARAcle requirements pending resources
Deeper discovery on LabWatch – R&D with JMonsite in Memphis
Key Upcoming Activities (Next Week)
Total # of TSAs # of TSAs Exited Last TSA Exit Date TSA Performance TSA Exit Status
4 0 30/09/2015
Total # of Projects # Projects Started # Projects Completed
4 4 0
